Genomics in the News

Genomics in the News2023-07-19T16:13:37-04:00
Multivariate genomic architecture of cortical thickness and surface area at multiple levels of analysis

February 19, 2023|Research|

Multivariate genomic architecture of cortical thickness and surface area at multiple levels of analysis

Recent work in imaging genetics suggests high levels of genetic overlap within cortical regions for cortical thickness (CT) and surface area (SA). In this manuscript by CGM investigators Jordan Smoller and Tian Ge, Genomic Structural Equation Modeling (Genomic SEM) was used to model this multivariate system of genetic relationships by applying and parsimoniously defining five genomic brain factors underlying both CT and SA along with a general factor capturing genetic overlap across all brain regions. Importantly, these factors were found to align with biologically and functionally relevant parcellations of the cortex. Stratified Genomic SEM was then used to identify specific categories of genes (e.g., neuronal cell types) that are disproportionately associated with pleiotropy across specific subclusters of brain regions, as indexed by the genomic factors. These powerful analyses provide key insights into the multivariate genomic architecture of two critical features of the cerebral cortex.

Read more in Nature Communications

February 19, 2023

Publication

CGM Primary Investigator

Polygenic risk score-based phenome-wide association study identifies novel associations for Tourette syndrome

February 18, 2023|Research|

Polygenic risk score-based phenome-wide association study identifies novel associations for Tourette syndrome

Tourette Syndrome (TS) is a complex neurodevelopmental disorder characterized by vocal and motor tics lasting more than a year. It is highly polygenic in nature with both rare and common previously associated variants. Epidemiological studies have shown TS to be correlated with other phenotypes, but large-scale phenome wide analyses in biobank level data have not been performed to date. In this study, by CGM investigator Jeremiah Scharf and colleagues, summary statistics from the latest meta-analysis of TS were used to calculate the polygenic risk score (PRS) of individuals in the UK Biobank data and applied a Phenome Wide Association Study (PheWAS) approach to determine the association of disease risk with a wide range of phenotypes. A total of 57 traits were found to be significantly associated with TS polygenic risk, including multiple psychosocial factors and mental health conditions such as anxiety disorder and depression. Additional associations were observed with complex non-psychiatric disorders such as type 2 diabetes, heart palpitations, and respiratory conditions. This analysis provides further evidence of shared genetic and phenotypic architecture of different complex disorders.

February 18, 2023

Publication Name

CGM Primary Investigator

Polygenic Scores Help Reduce Racial Disparities in Predictive Accuracy of Automated Type 1 Diabetes Classification Algorithms

February 17, 2023|Research|

Polygenic Scores Help Reduce Racial Disparities in Predictive Accuracy of Automated Type 1 Diabetes Classification Algorithms

In a study, led by CGM PI, Miriam Udler, and her colleagues they implemented an automated clinical algorithm and a type 1 diabetes polygenic score to identify individuals with type 1 diabetes in two large biobanks: MGB Biobank and BioMe (Mt. Sinai). They assessed the accuracy of the clinical algorithm compared to a gold standard of clinician diagnosis on chart review. The authors found that the clinical algorithm more accurately predicted type 1 diabetes status for self-reported White individuals, compared to other race/ethnicity groups. However, after updating the clinical algorithm to incorporate type 1 diabetes polygenic scores, the accuracy improved for all individuals, and the racial/ethnic disparity was reduced. These results demonstrate the potential for polygenic scores to aid in clinical phenotyping and to help reduce health disparities.

Read more in Diabetes Care and a podcast here.

February 17, 2023

Publication

CGM Primary Investigator

Miriam Udler
A cross-disorder dosage sensitivity map of the human genome

December 21, 2022|Research|

A cross-disorder dosage sensitivity map of the human genome

Large copy number variants (CNVs) are strong risk factors for human developmental disorders, yet interpretation of their functional consequences remains a considerable challenge, particularly for partial or complete duplication of a gene. Here, CGM Investigators Mike Talkowski and Harrison Brand jointly analyzed genetic data from nearly one-million individuals across 54 disorders to produce a ‘dosage sensitivity’ map of human diseases. This catalog nominated 163 disease-relevant loci and used a machine learning approach to create dosage sensitive metrics (pHaplo and pTriplo) that predicted 2,987 genes intolerant to deletion and 1,559 triplosensitive genes that were intolerant to duplication. These metrics were openly distributed and have been integrated into the DECIPHER database.

Read more in Science Direct

December 21, 2022

Publication

CGM Primary Investigator

Mike Talkowski

Harrison Brand

Whole genome sequence analysis of blood lipid levels in >66,000 individuals

December 20, 2022|Research|

Whole genome sequence analysis of blood lipid levels in >66,000 individuals

A team of CGM investigators and colleagues led by Pradeep Natarajan uncovered new genetic mechanisms for plasma lipid alterations using whole genome sequencing. The group expanded the allelic heterogeneity of lipids across diverse populations missed by current imputation methods. This work uncovered a new rare non-coding variant model of hyperlipidemia using new methods.

Read more in Nature Communications

December 20, 2022

Publication

CGM Primary Investigator

The Gene Curation Coalition: A global effort to harmonize gene-disease evidence resources

December 19, 2022|Research|

The Gene Curation Coalition: A global effort to harmonize gene-disease evidence resources

Documenting the evidence supporting the relationships between genes and disease is a critical element to enable clinical implementation of genes for rare disease diagnosis. The Gene Curation Coalition (GenCC), a large international consortium led by Heidi Rehm and Marina DiStefano, released their first paper on the GenCC’s work to build a public database (https://thegencc.org) of monogenic gene-disease relationships that have been curated using harmonized standards. The GenCC database functions like a “ClinVar for Genes” accepting and sharing submissions from the community (over 16,000 to date) and then facilitating discrepancy resolution through the collaborating GenCC members which includes ClinGen, OMIM, Orphanet, Genomics England, Australia Genomics, HUGO, and many private commercial testing labs.

To hear more about the GenCC, listen to the Genetics in Medicine GenePod podcast featuring an interview of Rehm and Marina DiStefano.

December 19, 2022

CGM Primary Investigator

Heidi Rehm
Large-scale sequencing identifies multiple genes and rare variants associated with Crohn’s disease susceptibility

December 18, 2022|Research|

Large-scale sequencing identifies multiple genes and rare variants associated with Crohn’s disease susceptibility

Genome-wide association studies (GWASs) have identified hundreds of loci associated with Crohn’s disease (CD). However, as with all complex diseases, robust identification of the genes dysregulated by noncoding variants typically driving GWAS discoveries has been challenging. Here, to complement GWASs and better define actionable biological targets, CGM investigators Mark Daly, Hailiang Huang, Aarno Palotie and colleagues  analyzed sequence data from more than 30,000 patients with CD and 80,000 population controls. They directly implicate ten genes in general onset CD for the first time to our knowledge via association to coding variation, four of which lie within established CD GWAS loci. In nine instances, a single coding variant is significantly associated, and in the tenth, ATG4C, we see additionally a significantly increased burden of very rare coding variants in CD cases. In addition to reiterating the central role of innate and adaptive immune cells as well as autophagy in CD pathogenesis, these newly associated genes highlight the emerging role of mesenchymal cells in the development and maintenance of intestinal inflammation.

Read more in Nature Genetics

December 18, 2022

Publication

CGM Primary Investigator

Associations Between Genetic Risk for Adult Suicide Attempt and Suicidal Behaviors in Young Children in the US

December 17, 2022|Research|

Associations Between Genetic Risk for Adult Suicide Attempt and Suicidal Behaviors in Young Children in the US

Suicide is among the leading cause of death in children and adolescents. While suicide risk is known to be heritable, statistically well-powered genomics studies of children have been sparse, limiting our understanding of whether, when, and how genetic risk factors of suicide affect children’s suicidal behaviors and risk outcomes. In this study, it was showed that genetic susceptibility to adulthood suicide attempts (SAs), assessed based on the largest GWAS of adult SAs, is associated with suicidal behaviors in 11,878 pre-adolescent US children, after accounting for children’s sociodemographic backgrounds, parental history of suicide, and children’s psychopathology problems. Although the predictive utility of the genetic risk factors is still modest, future efforts may benefit from utilizing genetic data when developing proactive screening and early intervention strategies for mitigating suicide risk in children.

Read more in Jama Psychiatry

December 17, 2022

Publication

CGM Primary Investigator

Increased diversity in a meta-analysis of asthma

December 16, 2022|Research|

Increased diversity in a meta-analysis of asthma

Asthma prevalence varies across populations, but it is unclear how much this is due to genetic factors. CGM PIs, Mark DalyAlicia Martin, and colleagues report findings from a large-scale GWAS of asthma. In their meta-analysis of 22 biobanks spanning diverse ancestries, they uncovered 179 loci associated with asthma, including 49 novel ones, and observed consistent genetic effects across ancestries and biobanks, suggesting that genetic effects are unlikely to drive most prevalence differences. They also found genetic correlations between asthma subtypes and co-morbidities. The study’s increased ancestral diversity relative to previous analyses improved polygenic risk prediction in non-European populations.

Read more in Cell Genomics

December 16, 2022

Publication

CGM Primary Investigator

Go to Top